What is the aim of sustained-release formulations in chronic therapy?

Prepare for the Drug Discovery and Healthcare Systems Test. Access flashcards and multiple-choice questions with hints and explanations. Ace your exam with our comprehensive resources!

Multiple Choice

What is the aim of sustained-release formulations in chronic therapy?

Sustained-release formulations aim to keep drug levels steady over a longer period so that you don’t have to take the medicine as often. In chronic therapy, the big advantage is improving adherence because dosing becomes less frequent and easier to fit into daily life. When patients only need to take a dose once daily (or even less often), they’re less likely to miss doses, which helps maintain consistent therapeutic exposure and effectiveness. Shortening the dosing interval would increase how often patients must take the drug, which can worsen adherence. While steadier levels can sometimes reduce peak-related adverse effects, that is a helpful consequence rather than the primary goal. And sustaining release does not automatically eliminate the need for monitoring.

Sustained-release formulations aim to keep drug levels steady over a longer period so that you don’t have to take the medicine as often. In chronic therapy, the big advantage is improving adherence because dosing becomes less frequent and easier to fit into daily life. When patients only need to take a dose once daily (or even less often), they’re less likely to miss doses, which helps maintain consistent therapeutic exposure and effectiveness.

Shortening the dosing interval would increase how often patients must take the drug, which can worsen adherence. While steadier levels can sometimes reduce peak-related adverse effects, that is a helpful consequence rather than the primary goal. And sustaining release does not automatically eliminate the need for monitoring.

More practice questions